↓ Skip to main content

Modulating the Rate and Rhythmicity of Perceptual Rivalry Alternations with the Mixed 5-HT2A and 5-HT1A Agonist Psilocybin

Overview of attention for article published in Neuropsychopharmacology, January 2005
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

patent
2 patents
wikipedia
2 Wikipedia pages

Readers on

mendeley
188 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Modulating the Rate and Rhythmicity of Perceptual Rivalry Alternations with the Mixed 5-HT2A and 5-HT1A Agonist Psilocybin
Published in
Neuropsychopharmacology, January 2005
DOI 10.1038/sj.npp.1300621
Pubmed ID
Authors

Olivia L Carter, John D Pettigrew, Felix Hasler, Guy M Wallis, Guang B Liu, Daniel Hell, Franz X Vollenweider

Abstract

Binocular rivalry occurs when different images are presented simultaneously to corresponding points within the left and right eyes. Under these conditions, the observer's perception will alternate between the two perceptual alternatives. Motivated by the reported link between the rate of perceptual alternations, symptoms of psychosis and an incidental observation that the rhythmicity of perceptual alternations during binocular rivalry was greatly increased 10 h after the consumption of LSD, this study aimed to investigate the pharmacology underlying binocular rivalry and to explore the connection between the timing of perceptual switching and psychosis. Psilocybin (4-phosphoryloxy-N,N-dimethyltryptamine, PY) was chosen for the study because, like LSD, it is known to act as an agonist at serotonin (5-HT)1A and 5-HT2A receptors and to produce an altered state sometimes marked by psychosis-like symptoms. A total of 12 healthy human volunteers were tested under placebo, low-dose (115 microg/kg) and high-dose (250 microg/kg) PY conditions. In line with predictions, under both low- and high-dose conditions, the results show that at 90 min postadministration (the peak of drug action), rate and rhythmicity of perceptual alternations were significantly reduced from placebo levels. Following the 90 min testing period, the perceptual switch rate successively increased, with some individuals showing increases well beyond pretest levels at the final testing, 360 min postadministration. However, as some subjects had still not returned to pretest levels by this time, the mean phase duration at 360 min was not found to differ significantly from placebo. Reflecting the drug-induced changes in rivalry phase durations, subjects showed clear changes in psychological state as indexed by the 5D-ASC (altered states of consciousness) rating scales. This study suggests the involvement of serotonergic pathways in binocular rivalry and supports the previously proposed role of a brainstem oscillator in perceptual rivalry alternations and symptoms of psychosis.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 188 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 5 3%
Switzerland 3 2%
Chile 1 <1%
Italy 1 <1%
Australia 1 <1%
Netherlands 1 <1%
United Kingdom 1 <1%
Sweden 1 <1%
China 1 <1%
Other 1 <1%
Unknown 172 91%

Demographic breakdown

Readers by professional status Count As %
Researcher 35 19%
Student > Bachelor 27 14%
Student > Ph. D. Student 24 13%
Student > Master 19 10%
Student > Doctoral Student 10 5%
Other 32 17%
Unknown 41 22%
Readers by discipline Count As %
Psychology 48 26%
Neuroscience 25 13%
Agricultural and Biological Sciences 20 11%
Medicine and Dentistry 20 11%
Pharmacology, Toxicology and Pharmaceutical Science 4 2%
Other 24 13%
Unknown 47 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 March 2024.
All research outputs
#4,958,728
of 23,770,218 outputs
Outputs from Neuropsychopharmacology
#2,133
of 4,216 outputs
Outputs of similar age
#17,779
of 144,633 outputs
Outputs of similar age from Neuropsychopharmacology
#11
of 34 outputs
Altmetric has tracked 23,770,218 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,216 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.2. This one is in the 47th percentile – i.e., 47% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 144,633 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 34 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.